Our Story
JCRC-ABT CellGene Innovations is dedicated to breaking barriers by offering advanced treatments like stem cell therapy, gene therapy, and immunotherapy. By combining science, innovation, and compassion, we aim to revolutionize healthcare and provide patients with the most advanced treatments available today. We believe that advanced healthcare should be a right, not a privilege.
Our Mission: Building Bridges to Better Health
At JCRC-ABT CellGene Innovations, we are more than a healthcare provider—we’re pioneers in regenerative medicine, committed to empowering communities across Africa with lifesaving therapies. With a focus on innovation, accessibility, and patient-centered care, our mission is to bring hope and healing to those who need it most. Through global partnerships, cutting-edge research, and a passion for change, we are closing the healthcare gap for low to middle-income communities and creating a healthier future for Africa.
About Us: JCRC-ABT CellGene Innovations Ltd
JCRC-ABT CellGene Innovations Ltd. is a pioneering collaboration between the Joint Clinical Research Centre (JCRC) and Asea BioTherapeutics (ABT). This partnership was established to revolutionize advanced therapies in Africa, focusing on cutting-edge solutions such as stem cell therapy, gene therapy, bone marrow transplants, and precision medicine. With a shared vision of improving access to high-quality, life-saving treatments, JCRC-ABT aims to set new benchmarks in healthcare innovation and affordability.
About JCRC
Founded in 1991, the Joint Clinical Research Centre is one of Uganda’s leading medical institutions. Renowned for its groundbreaking work in HIV/AIDS treatment and research, JCRC has expanded its expertise to include cancer care, clinical trials, and advanced medical research. The center is jointly owned by the Ministry of Health (MOH), the Ministry of Defence (MOD), and Makerere University. This collaborative ownership structure ensures that JCRC benefits from strong institutional support and a multidisciplinary approach to healthcare and research. Under the leadership of Dr. Cissy Kityo Mutuluuza, JCRC continues to serve as a beacon of hope, providing cutting-edge treatments to patients across Uganda and beyond.
About Asea BioTherapeutics (ABT)
Asea Biotherapeutics (ABT) Uganda Limited is a pioneering biopharmaceutical company dedicated to making advanced, cost-effective therapies accessible in underserved regions. Leveraging the WTO TRIPS Agreement, we produce high-quality specialty medicines, including stem cell and gene therapies, to address critical healthcare gaps.
Founded by Prof. Dr. Alexzander Asea, ABT collaborates with leading institutions like Uganda’s Joint Clinical Research Centre (JCRC) and Enexa Lab (USA) to drive innovation. With a strong focus on affordability and accessibility, we are transforming global healthcare through research, strategic partnerships, and scalable solutions.
Kris Kvavik, a seasoned entrepreneur and venture capitalist with over 25 years of experience in finance, technology, and high-performance computing, plays a key role in ABT’s strategic development and global expansion. His expertise spans AI, blockchain, and biotech commercialization, driving the company’s vision for innovative and sustainable healthcare solutions.
Dr. Hon. Elly Karuhanga, a distinguished lawyer, business leader, and former legislator, brings invaluable expertise in corporate governance, regulatory affairs, and high-level negotiations. As a key figure in Uganda’s legal, energy, and investment sectors, his strategic insights and leadership strengthen ABT’s industry positioning and partnerships.
Together, these founders have united their expertise to transform healthcare delivery, making advanced treatments more affordable and accessible to underserved communities
At JCRC-ABT, we are committed to creating a brighter future through science, technology, and innovation in healthcare.
Our Scientific Foundation
Immunotherapy
Immunotherapy enhances the immune system's natural ability to combat diseases like cancer and autoimmune conditions. This therapy is grounded in immunological research, focusing on stimulating or modifying immune responses to target specific diseases.
Read More
Bone Marrow Transplants
Bone marrow transplants replace damaged or diseased marrow with healthy cells, essential for treating blood disorders and certain cancers. Groundbreaking research has refined this therapy, improving survival rates and patient outcomes. Our facility employs state-of-the-art techniques to ensure safe and effective transplantation.
Read More
Gene Therapy
Gene therapy addresses diseases at their root cause by modifying or replacing defective genes. By targeting specific genetic abnormalities, this therapy offers transformative solutions for hereditary and rare disorders. Our research aligns with breakthroughs in CRISPR-Cas9 technology and other gene-editing methods, making precision medicine a reality.
Read More
Stem Cell Therapy
Stem cells are the body's natural repair system, capable of transforming into specialized cells to repair damaged tissues. This therapy is backed by extensive research demonstrating its effectiveness in conditions such as autoimmune diseases, degenerative disorders, and injury recovery. Our approach uses GMP-certified stem cells to ensure safety and efficacy, offering patients a promising alternative to conventional treatments.
Read More
Our Collaborative Research Network
By collaborating with trusted global leaders, JCRC-ABT provides patients with treatments backed by proven science, ethical sourcing, and uncompromising quality. We partner with renowned institutions like Karolinska University and Cellcolab to stay at the forefront of medical innovation. Our dedicated research facilities enable us to contribute to the global scientific community through peer-reviewed publications, clinical trials, and collaborative studies.
Testimonials & Case Studies
Reversing Neurological Decline
Condition: Multiple Sclerosis
Therapy Used: Stem Cell Therapy
Outcome: Patient experienced improved motor function, reduced inflammation, and greater mobility within six months of treatment.
Testimonial
“Living with multiple sclerosis felt like losing a part of myself every day. JCRC-ABT gave me hope through stem cell therapy. Today, I can walk without assistance and enjoy moments with my family again.” – Grace N.
Post-Cancer Recovery
Condition: Post-Chemotherapy Fatigue Therapy Used: Immunotherapy and Wellness Program Outcome: Boosted immune function, increased energy levels, and faster recovery times.
Testimonial
“Chemotherapy left me feeling drained, but JCRC-ABT’s recovery program restored my strength and vitality. Their care gave me the confidence to move forward with my life.” – Eleanor T.
Genetic Breakthrough
Condition: Sickle Cell Anemia
Therapy Used: Gene Therapy
Outcome: Genetic correction significantly reduced the frequency of sickle cell crises, enhancing the patient’s quality of life.
Testimonial
“For years, I lived with the constant pain and fear of sickle cell crises. Gene therapy at JCRC-ABT changed everything. I finally feel free to live my life without limits.” – David A.
Your Success Story Could Be Next
We’re honored to have been part of so many inspiring journeys, and we’re ready to support you on yours.
What is stem cell therapy?
Stem cell therapy is a regenerative treatment that uses stem cells to repair, replace, or regenerate damaged tissues and organs. These cells have the unique ability to develop into different cell types, making them effective for treating various conditions, including degenerative diseases, injuries, and immune disorders.
How do I qualify?
You can qualify for treatment by starting the application process on our website or by following this link: https://jcrc-abt.com/our-process/. Our lead physician will review your application and determine whether additional preclinical assessments, such as blood tests, MRI, or X-rays, are necessary. Once this evaluation is complete, you will receive medical clearance, and we will schedule your treatment date.
Is treatment safe?
Yes. Gene therapy is conducted under strict safety protocols and adheres to international standards. At JCRC-ABT, we partner with global leaders to ensure every procedure is safe and effective.
What is gene therapy?
Gene therapy is a cutting-edge medical treatment that involves modifying or replacing faulty genes to treat or prevent diseases. It works by delivering therapeutic genes into a patient’s cells to correct genetic disorders, enhance the body’s ability to fight diseases, or restore normal function.
How can I get started?
To get started, begin the application process on our website or follow this link: https://jcrc-abt.com/our-process/. Our medical team will review your application and determine if any preclinical assessments, such as blood tests, MRI, or X-rays, are needed. Once cleared, we will schedule your treatment.
